Teva Pharmaceutical Industries Ltd
NYSE · Healthcare · Pharmaceutical Preparations · Tel Aviv
TEVA chart
What traders are saying about $TEVA
Latest postsTeva Pharmaceutical Industries Ltd news
- Teva Pharmaceutical Industries (TEVA) Stock Forecasts
Yahoo Finance ·
- Fourteen brokerages set USD 46.08 target for Teva stock
ad-hoc-news.de ·
- Teva Pharmaceutical Industries Unit Buys Rights to BXCL501 From BioXcel Therapeutics
marketscreener.com ·
- Teva Pharmaceutical Industries (TEVA) Expected to Release Quarterly Earnings on Tuesday
MarketBeat ·
- Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline
Yahoo Finance ·
- Teva reports 44-week duvakitug data for Teva stock
ad-hoc-news.de ·
- Zacks downgrades Teva stock to Strong Sell below yearly high
ad-hoc-news.de ·
- Is Teva Pharmaceutical Industries (TEVA) Still Undervalued Following Its Recent Pullback?
Simply Wall Street ·
- Piper Sandler sets USD 44.00 target for Teva stock ahead of results
ad-hoc-news.de ·
- 106,238 Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by Sterling Capital Management LLC
MarketBeat ·
- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages
MarketBeat ·
- Teva Pharmaceutical Industries Limited (TEVA) Interactive Stock Chart - Yahoo Finance
Yahoo! Finance Canada ·
Teva Pharmaceutical Industries Ltd key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $17.26B | $16.54B | $15.85B | $14.93B |
| Net income | $1.41B | -$1.64B | -$559.0M | -$2.45B |
| Diluted EPS | $1.21 | $-1.45 | $-0.50 | $-2.20 |
| Total assets (year end) | $40.75B | $39.33B | $43.48B | $44.01B |
| Cash and equivalents (year end) | $3.56B | $3.30B | $3.23B | $2.80B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Teva Pharmaceutical Industries Ltd
- Ticker
- TEVA (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tel Aviv
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 818686
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Frequently asked questions
What exchange is Teva Pharmaceutical Industries Ltd listed on?
Teva Pharmaceutical Industries Ltd trades on the NYSE under the ticker symbol TEVA.
What industry is Teva Pharmaceutical Industries Ltd in?
Teva Pharmaceutical Industries Ltd is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Teva Pharmaceutical Industries Ltd headquartered?
Teva Pharmaceutical Industries Ltd's business address on file with the SEC is in Tel Aviv.
When does Teva Pharmaceutical Industries Ltd's fiscal year end?
Teva Pharmaceutical Industries Ltd's fiscal year ends on December 31.
How much revenue did Teva Pharmaceutical Industries Ltd report?
Teva Pharmaceutical Industries Ltd reported $17.26B in revenue for calendar year 2025, according to its SEC filings.